Showing results (31-40 of 64) with videos related to
Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancerAmir Onn, Arlene M Correa, Michael Gilcrease, et al.American Journal of Clinical Oncology|May 13, 2009
A phase II study of Lonafarnib (SCH66336) in patients with chemorefractory, advanced squamous cell carcinoma of the head and neckEmer O Hanrahan, Merrill S Kies, Bonnie S Glisson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2002
Initial clinical trial of oral TAC-101, a novel retinoic acid receptor-alpha selective retinoid, in patients with advanced cancerNaiyer A Rizvi, John L Marshall, Elizabeth Ness, et al.Cancer Causes & Control : CCC|May 17, 2003
Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States)Kim-Anh Do, Marcella M Johnson, Dorota A Doherty, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2004
Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markersCharles Lu, Jean-Charles Soria, Ximing Tang, et al.Cancer|March 13, 2010
Phase 2 study of carboplatin, docetaxel, and bevacizumab as frontline treatment for advanced nonsmall-cell lung cancerWilliam N William, Merrill S Kies, Frank V Fossella, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2004
Hypermethylation of the retinoic acid receptor-beta(2) gene in head and neck carcinogenesisEmile M Youssef, Dafna Lotan, Jean-Pierre Issa, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Identification of insulin-like growth factor binding protein-3 as a farnesyl transferase inhibitor SCH66336-induced negative regulator of angiogenesis in head and neck squamous cell carcinomaSeung-Hyun Oh, Woo-Young Kim, Jai-Hyun Kim, et al.International Journal of Radiation Oncology, Biology, Physics|October 4, 2005
A phase I/II study of neoadjuvant chemotherapy followed by radiation with boost chemotherapy for advanced T-stage nasopharyngeal carcinomaFaye M Johnson, Adam S Garden, J Lynn Palmer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
From Protocols to Publications: A Study in Selective Reporting of Outcomes in Randomized Trials in OncologyKanwal Pratap Singh Raghav, Sminil Mahajan, James C Yao, et al.Pageof 7